Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Share-based Compensation (2016 - 2026)

Collegium Pharmaceutical has reported Share-based Compensation over the past 10 years, most recently at $9.8 million for Q4 2025.

  • For Q4 2025, Share-based Compensation rose 28.4% year-over-year to $9.8 million; the TTM value through Dec 2025 reached $41.9 million, up 29.34%, while the annual FY2025 figure was $41.9 million, 29.34% up from the prior year.
  • Share-based Compensation for Q4 2025 was $9.8 million at Collegium Pharmaceutical, down from $9.8 million in the prior quarter.
  • Over five years, Share-based Compensation peaked at $11.5 million in Q1 2025 and troughed at $4.9 million in Q4 2021.
  • A 5-year average of $7.4 million and a median of $7.0 million in 2023 define the central range for Share-based Compensation.
  • Biggest five-year swings in Share-based Compensation: surged 442.16% in 2021 and later fell 12.65% in 2022.
  • Year by year, Share-based Compensation stood at $4.9 million in 2021, then grew by 15.43% to $5.7 million in 2022, then grew by 23.49% to $7.0 million in 2023, then increased by 8.48% to $7.6 million in 2024, then grew by 28.4% to $9.8 million in 2025.
  • Business Quant data shows Share-based Compensation for COLL at $9.8 million in Q4 2025, $9.8 million in Q3 2025, and $10.8 million in Q2 2025.